rs145040665

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000377.3(WAS):​c.538C>A​(p.His180Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00134 in 1,210,927 control chromosomes in the GnomAD database, including 1 homozygotes. There are 546 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. H180H) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0010 ( 0 hom., 36 hem., cov: 23)
Exomes 𝑓: 0.0014 ( 1 hom. 510 hem. )

Consequence

WAS
NM_000377.3 missense

Scores

2
2
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:7O:1

Conservation

PhyloP100: 1.44

Publications

5 publications found
Variant links:
Genes affected
WAS (HGNC:12731): (WASP actin nucleation promoting factor) The Wiskott-Aldrich syndrome (WAS) family of proteins share similar domain structure, and are involved in transduction of signals from receptors on the cell surface to the actin cytoskeleton. The presence of a number of different motifs suggests that they are regulated by a number of different stimuli, and interact with multiple proteins. Recent studies have demonstrated that these proteins, directly or indirectly, associate with the small GTPase, Cdc42, known to regulate formation of actin filaments, and the cytoskeletal organizing complex, Arp2/3. Wiskott-Aldrich syndrome is a rare, inherited, X-linked, recessive disease characterized by immune dysregulation and microthrombocytopenia, and is caused by mutations in the WAS gene. The WAS gene product is a cytoplasmic protein, expressed exclusively in hematopoietic cells, which show signalling and cytoskeletal abnormalities in WAS patients. A transcript variant arising as a result of alternative promoter usage, and containing a different 5' UTR sequence, has been described, however, its full-length nature is not known. [provided by RefSeq, Jul 2008]
WAS Gene-Disease associations (from GenCC):
  • Wiskott-Aldrich syndrome
    Inheritance: XL, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • X-linked severe congenital neutropenia
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • thrombocytopenia 1
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012371749).
BP6
Variant X-48686113-C-A is Benign according to our data. Variant chrX-48686113-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 36912.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00103 (116/112767) while in subpopulation NFE AF = 0.0018 (96/53303). AF 95% confidence interval is 0.00151. There are 0 homozygotes in GnomAd4. There are 36 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High AC in GnomAd4 at 116 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WASNM_000377.3 linkc.538C>A p.His180Asn missense_variant Exon 6 of 12 ENST00000376701.5 NP_000368.1 P42768A0A024QYX8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WASENST00000376701.5 linkc.538C>A p.His180Asn missense_variant Exon 6 of 12 1 NM_000377.3 ENSP00000365891.4 P42768

Frequencies

GnomAD3 genomes
AF:
0.00103
AC:
116
AN:
112713
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000129
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000281
Gnomad ASJ
AF:
0.00451
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000161
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00180
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00101
AC:
186
AN:
183265
AF XY:
0.00103
show subpopulations
Gnomad AFR exome
AF:
0.000228
Gnomad AMR exome
AF:
0.000255
Gnomad ASJ exome
AF:
0.00548
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00155
Gnomad OTH exome
AF:
0.000663
GnomAD4 exome
AF:
0.00137
AC:
1506
AN:
1098160
Hom.:
1
Cov.:
33
AF XY:
0.00140
AC XY:
510
AN XY:
363518
show subpopulations
African (AFR)
AF:
0.0000758
AC:
2
AN:
26401
American (AMR)
AF:
0.000426
AC:
15
AN:
35204
Ashkenazi Jewish (ASJ)
AF:
0.00495
AC:
96
AN:
19386
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30206
South Asian (SAS)
AF:
0.000499
AC:
27
AN:
54136
European-Finnish (FIN)
AF:
0.0000247
AC:
1
AN:
40533
Middle Eastern (MID)
AF:
0.000967
AC:
4
AN:
4135
European-Non Finnish (NFE)
AF:
0.00153
AC:
1288
AN:
842065
Other (OTH)
AF:
0.00158
AC:
73
AN:
46094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.451
Heterozygous variant carriers
0
58
117
175
234
292
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00103
AC:
116
AN:
112767
Hom.:
0
Cov.:
23
AF XY:
0.00103
AC XY:
36
AN XY:
34919
show subpopulations
African (AFR)
AF:
0.000129
AC:
4
AN:
31075
American (AMR)
AF:
0.000281
AC:
3
AN:
10673
Ashkenazi Jewish (ASJ)
AF:
0.00451
AC:
12
AN:
2658
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3606
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2799
European-Finnish (FIN)
AF:
0.000161
AC:
1
AN:
6216
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
219
European-Non Finnish (NFE)
AF:
0.00180
AC:
96
AN:
53303
Other (OTH)
AF:
0.00
AC:
0
AN:
1533
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00157
Hom.:
77
Bravo
AF:
0.00110
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.00138
AC:
4
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00208
AC:
14
ExAC
AF:
0.000840
AC:
102
EpiCase
AF:
0.00338
EpiControl
AF:
0.00196

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:7Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Jul 15, 2016
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 01, 2020
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 15, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2Other:1
Jan 19, 2017
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Jun 04, 2015
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Thrombocytopenia 1 Benign:1
Oct 02, 2015
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

WAS-related disorder Benign:1
Jul 02, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Wiskott-Aldrich syndrome;C1839163:Thrombocytopenia 1;C1845987:X-linked severe congenital neutropenia Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.19
CADD
Benign
15
DANN
Benign
0.95
DEOGEN2
Benign
0.0077
T;T
FATHMM_MKL
Benign
0.34
N
LIST_S2
Benign
0.61
T;T
M_CAP
Pathogenic
0.70
D
MetaRNN
Benign
0.012
T;T
MetaSVM
Pathogenic
0.86
D
MutationAssessor
Benign
1.8
.;L
PhyloP100
1.4
PrimateAI
Uncertain
0.62
T
PROVEAN
Benign
-0.16
N;N
REVEL
Uncertain
0.41
Sift
Benign
0.48
T;T
Sift4G
Benign
0.32
T;T
Polyphen
0.48
.;P
Vest4
0.088
MVP
0.84
MPC
0.77
ClinPred
0.0080
T
GERP RS
4.3
Varity_R
0.15
gMVP
0.38
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145040665; hg19: chrX-48544502; API